Invesco Biotechnology & Genome ETF
PBE
PBE
89 hedge funds and large institutions have $56.5M invested in Invesco Biotechnology & Genome ETF in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-12
Holders Change %
-11.88%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
13
Reduced
28
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCA
101
Snowden Capital Advisors
New York
| – | -$78K | -1,100 | Closed |
|
|
RPCONE
102
Retirement Planning Company of New England
Warwick,
Rhode Island
| – | -$66K | -930 | Closed |
|
|
CFCI
103
Comprehensive Financial Consultants Institutional
Bloomington,
Indiana
| – | -$13K | -230 | Closed |
|
|
EWM
104
Elmwood Wealth Management
Berkeley,
California
| – | -$14K | -200 | Closed |
|
|
GEA
105
Glen Eagle Advisors
Kingston,
New Jersey
| – | -$12.5K | -175 | Closed |
|
|
FHA
106
First Horizon Advisors
Memphis,
Tennessee
| – | -$11K | -156 | Closed |
|
|
MTWM
107
Masso Torrence Wealth Management
Marlton,
New Jersey
| – | -$11K | -151 | Closed |
|
108
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$8K | -112 | Closed |
|
|
NFSG
109
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$7K | -100 | Closed |
|